Similar Posts
CTMR represents at the 50th European Muscle Conference Florence 2023
BykdDr. Mike Regnier is an invited speaker at the 50th European Muscle Conference (EMC) coming up in September 2023. The EMC will be in held in Florence, Italy. Dr. Regnier will be the “DISEASE MODELS” session chair and his talk title will be: “Molecular mechanisms of contractile abnormalities for the MYH7 variant G256E”. Graduate student,…
UW Center for Translational Muscle Research (CTMR) 2022 symposium brings the muscle community together!
BykdOn October 24th, 2022 the CTMR held its annual symposium. Over 130 people registered and researchers from a variety of backgrounds shared their work during our first in-person symposium since the founding of the Center in 2019. CTMR director, Dr, Michael Regnier welcomed scientists from near and far. Although most of the attendees were from…
CTMR Pilot Funding Available – Deadline Feb 16th
Byctmr1Proposals to the Pilot Grant program of the UW Center for Translational Muscle Research (CTMR) are now being accepted. This program supports the development of exciting new muscle research by enabling investigators to obtain preliminary data needed to apply for follow-on funding and receive training in new skills. Funding up to $25,000 (direct costs) is available. Applications are due…
Eesha Murali was awarded a Washington Research Foundation fellowship!
BykdPlease join us in congratulating Eesha Murali on her Washington Research Foundation (WRF) Fellowship!
2022 Myofilament Meeting
Byctmr1In May, CTMR Investigators participated in the 2022 Myofilament research conference “Myofilament Form and Function: Determinants of Sarcomeric Contractility” in Madison, Wisconsin.
Dr. Ru Gunawardane joins CTMR External Advisory Board
Byctmr1We are excited to announce that Ruwanthi (Ru) Gunawardane, Ph.D. is joining CTMR as a member of our External Advisory Board. Ru was recently named Executive Director of the Allen Institute for Cell Science in 2020 after spending five years at Amgen, where she worked on assay development for multiple drug targets spanning oncology, inflammation,…

